Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2007
01/17/2007EP1742707A2 Treatment of cns disorders using cns target modulators
01/17/2007EP1383751B1 Novel azoles having an insecticidal action
01/17/2007EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents
01/17/2007EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
01/17/2007CN1898237A Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
01/17/2007CN1898236A Processes for preparation of ziprasidone
01/17/2007CN1898235A Heterocyclic derivatives as gpcr receptor agonists
01/17/2007CN1898221A Modulators of atp-binding cassette transporters
01/17/2007CN1898216A Amide derivatives
01/17/2007CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides
01/17/2007CN1898208A Amide derivative and medicine
01/17/2007CN1898206A Allosteric modulators of metabotropic glutamate receptors
01/17/2007CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
01/17/2007CN1896070A 2- and 2,5-substituted phenylketo-enols
01/17/2007CN1896069A Substituted-thiazole-4-ketone, its preparation and use
01/17/2007CN1295222C Improved method for preparing thiazolidine-2,4-dione derivative
01/17/2007CN1295221C Substituted heterocyclic compounds
01/16/2007US7163952 Azole compound and medicinal use thereof
01/16/2007US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives
01/16/2007US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation.
01/16/2007US7163937 Cyclic derivatives as modulators of chemokine receptor activity
01/16/2007CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
01/11/2007WO2007005510A1 N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
01/11/2007WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION
01/11/2007WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease
01/11/2007WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
01/11/2007WO2007004038A1 Aminothiazole derivatives as agonists of the thrombopoietin receptor
01/11/2007WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/11/2007WO2007003961A2 Gpcr agonists
01/11/2007WO2007003960A1 Gpcr agonists
01/11/2007WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
01/11/2007WO2006117211A3 Urea derivatives methods for their manufacture and uses thereof
01/11/2007WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases
01/11/2007WO2006032342A3 Carbonyl compound-containing drug and the use thereof
01/11/2007WO2006020959A3 Substituted benzofused heterocycles
01/11/2007WO2006014359A3 Compounds useful for inhibiting chk1
01/11/2007WO2006009734A8 Gonadotropin releasing hormone receptor antagonists
01/11/2007US20070010566 Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
01/11/2007US20070010563 Novel methods for the treatment of inflammatory diseases
01/11/2007US20070010557 Novel amides useful for treating pain
01/11/2007US20070010556 Thiophene derivatives as chk 1 inhibitors
01/11/2007US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use
01/11/2007US20070010534 Novel compounds
01/11/2007US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/11/2007US20070010532 3-Pyridylcarboxamide derivatives as pesticidal agents
01/11/2007US20070010528 excellent efficacy, oral absorbability, sustained effect, fewer side effects; for thrombosis; anticoagulants; N-(4-((4-( 3-((6-chloro-2-naphthyl)sulfonyl)propanoyl)-1-piperazinyl)methyl)-3-methyl-1,3-thiazol-2(3H)-ylidene)-N-methylamine
01/11/2007US20070010526 Therapeutic isoquinoline compounds
01/11/2007US20070010509 Cycloamine ccr5 receptor antagonists
01/11/2007US20070010457 Caspase inhibitors and uses thereof
01/11/2007US20070009980 Continuous fluorogenic analyte assays with dendritic amplification of signal
01/11/2007CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments
01/11/2007CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation
01/11/2007CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/11/2007CA2611688A1 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
01/10/2007EP1741715A1 Epothilone derivatives and their synthesis and use
01/10/2007EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
01/10/2007EP1741709A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/10/2007EP1741708A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
01/10/2007EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
01/10/2007EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
01/10/2007EP1741428A2 Cell adhesion inhibitors
01/10/2007EP1740583A1 Oxadiazolone derivatives as ppar delta agonists
01/10/2007EP1740582A1 Acyl dihydro pyrrole derivatives as hcv inhibitors
01/10/2007EP1740581A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer"s disease
01/10/2007EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
01/10/2007EP1740576A1 Novel piperidine substituted diaminothiazoles
01/10/2007EP1740574A2 4-amino-5-cyanopyrimidine derivatives
01/10/2007EP1740569A1 Imidazole derivatives used as tafia inhibitors
01/10/2007EP1740568A2 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease.
01/10/2007EP1740544A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
01/10/2007EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors
01/10/2007EP1740531A1 Indene derivatives and process for the preparation thereof
01/10/2007EP1740185A1 Benzodiazepines for treating or preventing rsv infection
01/10/2007EP1740155A1 Polycylic thiazoles as potassium ion channel modulators
01/10/2007EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence
01/10/2007CN1894243A 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
01/10/2007CN1894242A Novel oxazolidinone derivatives
01/10/2007CN1894241A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5
01/10/2007CN1894239A Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
01/10/2007CN1894238A Diamine derivatives
01/10/2007CN1894234A 二肽基肽酶抑制剂 Dipeptidyl peptidase inhibitors
01/10/2007CN1894225A (3,4-disubstituted)propanoic carboxylates as SLP (EDG) receptor agonists
01/10/2007CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
01/10/2007CN1893945A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
01/10/2007CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine
01/10/2007CN1891689A Aliphatic nitrogen - containing 5 - membered ring compound
01/10/2007CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof
01/09/2007US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders
01/09/2007US7160923 Polyamine analogues as therapeutic and diagnostic agents
01/09/2007US7160912 Oxazolidinone derivative of the formula (I) or a salt thereof, or a stereoisomer thereof, where R1 represents NHR4 wherein R4 represents thio(C1-C10)acyl, C( . dbd. S)-cyclo(C3-C8)alkoxy, C( .dbd. S) (C1-C10)alkoxy, C( .dbd.S
01/09/2007US7160910 Anti-sickling agents
01/09/2007US7160902 Amide derivatives and methods of their use
01/09/2007US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives
01/09/2007US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors
01/09/2007US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same
01/09/2007US7160889 Quinazoline compounds
01/09/2007US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
01/09/2007US7160877 Aliphatic nitrogen-containing 5-membered ring compound
01/09/2007US7160870 Thrombopoietin mimetics
01/09/2007CA2394720C Cyanomethylene compounds and fungicidal compositions